Dr. Tom Weidig, the brain behind the Stuttering Brain blog, joins Peter Reitzes to discuss his five stuttering predictions for 2012. Dr. Weidig predicts that: 1. A Dutch study (or the findings) due out soon will show no difference between Lidcombe treatment for preschoolers and a Demands and Capacities treatment approach.
2. More input from mainstream scientists on stuttering research relating to genes and biochemistry.
3. More trials on drugs but nothing much happening.
4. Discussions on blogs and podcasts might switch more to social media, especially Facebook.
5. The results from the large long-term Phase IIb trial on Pagoclone will be released. They will show that the control group (who took a placebo pill) show significant improvements. The study of this effect will force us to reconsider all outcome studies ever done and compare them to the control groups’ improvements.
Dr. Weidig also reviews the predictions he made at the very end of 2010 for 2011.
For more information on Lidcombe stuttering treatment, listeners may wish to listen to these StutterTalk podcasts:
StutterTalk® is a 501 (c)(3) non-profit organization dedicated to talking openly about stuttering. StutterTalk is the first and longest running podcast on stuttering. Since 2007 we have published more than 700 podcasts which are heard in 180 countries.
25 Dec 2011
Predictions for 2012 with the Stuttering Brain (311)
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Google Podcasts | Stitcher | TuneIn | RSS
Dr. Tom Weidig, the brain behind the Stuttering Brain blog, joins Peter Reitzes to discuss his five stuttering predictions for 2012. Dr. Weidig predicts that:
1. A Dutch study (or the findings) due out soon will show no difference between Lidcombe treatment for preschoolers and a Demands and Capacities treatment approach.
2. More input from mainstream scientists on stuttering research relating to genes and biochemistry.
3. More trials on drugs but nothing much happening.
4. Discussions on blogs and podcasts might switch more to social media, especially Facebook.
5. The results from the large long-term Phase IIb trial on Pagoclone will be released. They will show that the control group (who took a placebo pill) show significant improvements. The study of this effect will force us to reconsider all outcome studies ever done and compare them to the control groups’ improvements.
Dr. Weidig also reviews the predictions he made at the very end of 2010 for 2011.
For more information on Lidcombe stuttering treatment, listeners may wish to listen to these StutterTalk podcasts: